Musculoskeletal Symptoms in Patients With Cryopyrin-Associated Periodic Syndromes: A Large Database Study

Archive ouverte

Houx, Laetitia | Hachulla, Eric | Kone-Paut, Isabelle | Quartier, Pierre | Touitou, Isabelle | Guennoc, Xavier | Grateau, Gilles | Hamidou, Mohamed | Neven, Bénédicte | Berthelot, Jean-Marie | Lequerré, Thierry | Pillet, Pascal | Lemelle, Irène | Fischbach, Michel | Duquesne, Agnès | Le Blay, Pierre | Le Jeunne, Claire | Stirnemann, Jérome | Bonnet, Christine | Gaillard, Dominique | Alix, Lilian | Touraine, Renaud | Garcier, François | Bedane, Christophe | Jurquet, Anne-Laure | Duffau, Pierre | Smail, Amar | Frances, Camille | Grall-Lerosey, Martine | Cathebras, Pascal | Tran, Tu Anh | Morell-Dubois, Sandrine | Pagnier, Anne | Richez, Christophe | Cuisset, Laurence | Devauchelle-Pensec, Valérie

Edité par CCSD ; Wiley -

International audience. Objective: To determine the type and frequency of musculoskeletal symptoms at onset and during followup of cryopyrin-associated periodic syndromes (CAPS).Methods: We retrospectively recorded the articular and muscular symptoms of patients with CAPS followed up in French hospitals. Data were presented as frequencies or the median (range), and patient groups were compared using chi-square test, Fisher's exact test, and Mann-Whitney test.Results: The study included 133 patients (33 children), 20 with familial cold autoinflammatory syndrome, 88 with Muckle-Wells syndrome, 22 with chronic infantile neurologic, cutaneous, articular syndrome, and 3 with unclassified CAPS. The median age was 35 years (range 0-78 years) at the time of the study, 1 year (range 0-41 years) at symptom onset, and 23 years (range 0-58 years) at diagnosis. The disease was sporadic in 17% of the patients. Cutaneous symptoms predominated at onset (77%), followed by articular symptoms (30%). The p.Thr348Met and p.Arg260Trp NLRP3 mutations were significantly associated with the presence and absence of articular symptoms at onset, respectively. During followup, 86% of the patients had musculoskeletal symptoms, 88% had arthralgia, and 58% had arthritis, but only 9% had joint destruction. Tendinopathies occurred in 21.5% of the patients, tender points in 16.5%, and myalgia in 33%. Only 3 patients had typical knee deformities. Radiographs were rarely obtained. Except for bone deformities, osteoarticular symptoms occurred at similar frequencies in the different CAPS phenotypes.Conclusion: Joint manifestations were frequent in all CAPS phenotypes. Bone deformities were rare. Musculoskeletal manifestations varied within given families but tended to worsen over time.

Consulter en ligne

Suggestions

Du même auteur

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Archive ouverte | Avouac, Jérôme | CCSD

International audience. Background: Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab c...

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

Archive ouverte | Aeschlimann, Florence | CCSD

International audience. Objectives: There is little known about the impact of SARS-CoV-2 on patients with inflammatory rheumatic and musculoskeletal diseases (iRMD). We examined epidemiological characteristics assoc...

Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation

Archive ouverte | Cosson, Camille | CCSD

International audience. NLRP3-associated autoinflammatory disease is a heterogenous group of monogenic conditions caused by NLRP3 gain-of-function mutations. The poor functional characterization of most NLRP3 varian...

Chargement des enrichissements...